Is the Schwab U.S. Dividend Equity ETF the Right Buy Right Now?

SCHD is up nearly 18%-19% year to date in 2026 and is outperforming Vanguard S&P 500 ETF by about 7 percentage points, supported by its dividend profile and a still-defensive sector mix. However, tech exposure has risen to more than 15% of assets, with Qualcomm and Texas Instruments now the two largest holdings at roughly 12% combined, making performance more sensitive to the ongoing AI-led market rotation. Rising inflation and a potentially higher-for-longer Fed stance could aid SCHD if investors rotate away from growth stocks.

Analysis

SCHD’s outperformance is less a pure dividend story than a factor composition story: the fund has become an accidental beneficiary of AI-era concentration in a handful of cash-rich semi/telecom franchises. That matters because the portfolio now behaves more like a quality-tilted barbell than a classic low-beta income vehicle, so its upside has increased, but so has its dependence on the same capex/AI spend cycle that drives growth benchmarks.

The second-order effect is that SCHD now has a built-in hedge against the market’s narrow leadership. If rates stay higher for longer and earnings breadth remains weak, its staples/healthcare base should absorb some multiple compression while the yield supports total return. But if AI capex re-accelerates and semis regain leadership, the fund’s recent sector drift can still underperform the fastest compounders because its index rules cap winners before they can become true momentum vehicles.

The key risk is that investors extrapolate the recent rebound in dividend ETFs as a durable style shift. That’s likely premature unless inflation re-accelerates enough to keep real yields elevated and extend the market’s rotation out of long-duration growth for several more months. Conversely, any clear signal that the Fed is closer to easing, or that AI demand is inflecting again, would quickly re-open the performance gap versus SCHD.

The contrarian take: SCHD is no longer the anti-tech trade many assume it is. The fund has partially imported the market’s secular winners through dividend screening, which reduces diversification precisely when investors may think they are buying it. That creates an interesting setup where the best entry may be on a growth-led market rally, when the ETF’s relative performance lags but its yield/quality discount widens.

Key Decisions for Investors

• Use SCHD as a defensive equity sleeve only if paired with explicit growth exposure; otherwise it is not a clean hedge against AI risk anymore. Time horizon: 3-12 months.
• Relative-value pair: long SCHD / short QQQ on any renewed tech squeeze; thesis is multiple dispersion compression if real rates stay sticky. Risk/reward improves if 10Y yields move above recent ranges.
• For income-oriented books, prefer QCOM and TXN over broad dividend ETFs for a targeted quality-yield expression; both have direct upside if semis breadth holds, but tighter downside if AI leadership fades. Time horizon: 6-18 months.
• If inflation data re-accelerates and rate-cut odds get pushed out, add SCHD on weakness as a partial beneficiary of factor rotation away from long-duration growth. Stop if breadth returns to mega-cap tech within 2-4 weeks.
• Avoid treating SCHD as a low-vol substitute for bonds in 2026; its hidden tech beta means it can underperform precisely when rates rise and equity dispersion widens.